Katelyn Romm to Tobacco
This is a "connection" page, showing publications Katelyn Romm has written about Tobacco.
Connection Strength
0.917
-
Socioecological Predictors of Change in Adolescent Tobacco Use Across Waves 1-4 of the Population Assessment of Tobacco and Health Study. J Adolesc Health. 2023 03; 72(3):375-382.
Score: 0.201
-
Psychosocial predictors of longitudinal changes in tobacco and cannabis use among young adults. Addict Behav. 2022 06; 129:107264.
Score: 0.189
-
Transitions in tobacco use profiles among adolescents: Results from the Population Assessment of Tobacco and Health (PATH) study waves 3 and 4. Drug Alcohol Depend. 2022 03 01; 232:109272.
Score: 0.188
-
IQOS Use and Interest by Sociodemographic and Tobacco Behavior Characteristics among Adults in the US and Israel. Int J Environ Res Public Health. 2023 Feb 10; 20(4).
Score: 0.051
-
Longitudinal transitions in adolescent polytobacco use across waves 1-4 of the Population Assessment of Tobacco and Health study. Addiction. 2023 04; 118(4):727-738.
Score: 0.050
-
State T21, Restrictions on Flavored E-Cigarette Products, and Non-Medical Cannabis Sales Legalization in Relation to Young Adult Reports of Vape Shop Age Verification and Product Offerings: A Multilevel Analysis. Int J Environ Res Public Health. 2022 Nov 16; 19(22).
Score: 0.050
-
Correlates of Perceptions, Use, and Intention to Use Heated Tobacco Products Among US Young Adults in 2020. Nicotine Tob Res. 2022 Nov 12; 24(12):1968-1977.
Score: 0.050
-
The Impact of Recent Tobacco Regulations and COVID-19 Restrictions and Implications for Future E-Cigarette Retail: Perspectives from Vape and Vape-and-Smoke Shop Merchants. Int J Environ Res Public Health. 2022 03 24; 19(7).
Score: 0.048
-
IQOS Marketing in the US: The Need to Study the Impact of FDA Modified Exposure Authorization, Marketing Distribution Channels, and Potential Targeting of Consumers. Int J Environ Res Public Health. 2021 10 08; 18(19).
Score: 0.046
-
Cumulative disadvantage as a framework for understanding rural tobacco use disparities. Exp Clin Psychopharmacol. 2021 Oct; 29(5):429-439.
Score: 0.045